New Citations to WVU Law Scholarship, April to June 2023

The scholarship of West Virginia University College of Law faculty members is frequently cited as authority in numerous legal disciplines. The following is a list of faculty authored works cited and made available on Westlaw Precision between April 1, 2023 and June 30, 2023.

Valarie Blake

Professor Sean Tu Publishes New Opinion Piece in JAMA

West Virginia College of Law professor S. Sean Tu recently published a new opinion piece in JAMA. The article, titled  "Free Speech Challenges to the Inflation Reduction Act," is co-authored by Professor Tu with Rebecca Tushnet of Harvard Law School.  It was published online by the journal on August 29, 2023.

The article discusses the First Amendment free speech claims raised by drug manufacturers in lawsuits brought after the passage of the Inflation Reduction Act of 2022.  The IRA attempts to lower prescription drug prices, insurance premiums, and out-of-pocket costs for patients. 

Professor Sean Tu Interviewed by West Virginia Public Radio on Orphan Drugs

West Virginia University College of Law professor S. Sean Tu was recently interviewed on West Virginia Public Radio.  Professor Tu was interviewed by Eric Douglas on the topic of the pharmaceutical industry and "orphan drugs."

Listen to Professor Tu's interview, "WVU Professor: Pharma Industry Making Billions on Orphan Drugs," online at WV Public Broadcasting: https://wvpublic.org/wvu-professor-pharma-industry-making-billions-on-orphan-drugs/

WVU College of Law SSRN Paper Series Publishes Volume 11, Issue 1

The West Virginia University College of Law Research Paper Series published Volume 11, Issue 1 on May 16, 2023. The following authors were featured for their new scholarship recently published to SSRN:

Joshua E. Weishart, Brief of Amici Curiae Constitution and Education Law Scholars in Support of Respondents in West Virginia v. Beaver, No. 2023-001

Professor Sean Tu Publishes New Article in JAMA on Orphan Drug Act Designations

West Virginia University College of Law professor  S. Sean Tu recently published a new Research Letter in JAMA. The article, titled  "Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act Designation," analyzes sales revenue earned in the first 5 years for drugs with and without an initial orphan designation.  Professor Tu co-authored with work with Sarosh Nagar; Aaron S. Kesselheim, Zhigang Lu, and Benjamin N. Rome, all of whom are affiliated with Brigham and Women’s Hospital in Boston, Massachusetts, It was published online by the journal on May 9, 2023.

Find more of Professor Tu's scholarship on  SSRN.